Publicação
Clostridium difficile infection in Europe: a hospital-based survey
| dc.contributor.author | Bauer, MP | |
| dc.contributor.author | Notermans, DW | |
| dc.contributor.author | van Benthem, BH | |
| dc.contributor.author | Brazier, JS | |
| dc.contributor.author | Wilcox, MH | |
| dc.contributor.author | Rupnik, M | |
| dc.contributor.author | Monnet, DL | |
| dc.contributor.author | van Dissel, JT | |
| dc.contributor.author | Kuijper, EJ | |
| dc.contributor.author | Machado, Jorge | |
| dc.date.accessioned | 2012-02-27T11:56:35Z | |
| dc.date.available | 2012-02-27T11:56:35Z | |
| dc.date.issued | 2011-01 | |
| dc.description | Comment in Lancet. 2011 Jan 1;377(9759):8-9. Lancet. 2011 Apr 23;377(9775):1407. | por |
| dc.description.abstract | BACKGROUND: Little is known about the extent of Clostridium difficile infection in Europe. Our aim was to obtain a more complete overview of C difficile infection in Europe and build capacity for diagnosis and surveillance. METHODS: We set up a network of 106 laboratories in 34 European countries. In November, 2008, one to six hospitals per country, relative to population size, tested stool samples of patients with suspected C difficile infection or diarrhoea that developed 3 or more days after hospital admission. A case was defined when, subsequently, toxins were identified in stool samples. Detailed clinical data and stool isolates were collected for the first ten cases per hospital. After 3 months, clinical data were followed up. FINDINGS: The incidence of C difficile infection varied across hospitals (weighted mean 4·1 per 10,000 patient-days per hospital, range 0·0-36·3). Detailed information was obtained for 509 patients. For 389 of these patients, isolates were available for characterisation. 65 different PCR ribotypes were identified, of which 014/020 (61 patients [16%]), 001 (37 [9%]), and 078 (31 [8%]) were the most prevalent. The prevalence of PCR-ribotype 027 was 5%. Most patients had a previously identified risk profile of old age, comorbidity, and recent antibiotic use. At follow up, 101 (22%) of 455 patients had died, and C difficile infection played a part in 40 (40%) of deaths. After adjustment for potential confounders, an age of 65 years or older (adjusted odds ratio 3·26, 95% CI 1·08-9·78; p=0·026), and infection by PCR-ribotypes 018 (6·19, 1·28-29·81; p=0·023) and 056 (13·01; 1·14-148·26; p=0·039) were significantly associated with complicated disease outcome. INTERPRETATION: PCR ribotypes other than 027 are prevalent in European hospitals. The data emphasise the importance of multicountry surveillance to detect and control C difficile infection in Europe. | por |
| dc.description.sponsorship | FUNDING: European Centre for Disease Prevention and Control | por |
| dc.identifier.citation | Lancet. 2011 Jan 1;377(9759):63-73 | por |
| dc.identifier.issn | 0140-6736 | |
| dc.identifier.other | doi:10.1016/S0140-6736(10)61266-4. | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/645 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Elsevier | por |
| dc.relation.publisherversion | http://www.sciencedirect.com/science/article/pii/S0140673610612664 | por |
| dc.subject | Clostridium Difficile | por |
| dc.subject | Infection | por |
| dc.subject | Hospital Infection | por |
| dc.subject | Hospital | por |
| dc.subject | Nosocomial | por |
| dc.subject | Europe | por |
| dc.subject | Infecções Gastrointestinais | por |
| dc.title | Clostridium difficile infection in Europe: a hospital-based survey | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 73 | por |
| oaire.citation.startPage | 63 | por |
| rcaap.rights | restrictedAccess | por |
| rcaap.type | article | por |
Ficheiros
Principais
1 - 1 de 1
Miniatura indisponível
- Nome:
- Clostridium difficile infection in Europe a hospital based survey Lancet 2011.pdf
- Tamanho:
- 919.7 KB
- Formato:
- Adobe Portable Document Format
Licença
1 - 1 de 1
Miniatura indisponível
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
